The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Can Lupus Be Prevented? Research Reveals Clues to Who’s Most Likely to Transition to Classified Disease

Can Lupus Be Prevented? Research Reveals Clues to Who’s Most Likely to Transition to Classified Disease

February 25, 2020 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“Women had a much higher rate of transition to lupus compared with their male family members,” said Dr. James. The study also examined how those who transitioned were related to the original lupus patient. “We thought this would be all sisters, but what we found was that there were transitions in all kinds of family members, including cousins, nieces and a few nephews of lupus patients too.”

You Might Also Like
  • Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus
  • 2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed
  • New Study Reveals Limitations in ANA Test Kits for Lupus
Explore This Issue
March 2020
Also By This Author
  • Tips for Implementing Ultrasound Training in Rheumatology Fellowships

Each person who transitioned to lupus had at least a positive ANA test and most also had either a clinical symptom or another autoantibody. Analysis of the transitioned patients’ baseline results on the Connective Tissue Disease Screening Questionnaire showed that individuals with higher scores were more likely to transition to lupus.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

When they looked at soluble mediators, “we found altered cytokines … in first-degree blood relatives of lupus patients who transitioned. First-degree relatives who transitioned had higher levels of BLyS even at baseline compared with those who did not transition and with family members who were ANA negative and unaffected,” said Dr. James.

The researchers also found increased levels of TNF receptor 1, MCP-3 and stem cell factor in relatives who transitioned to SLE, but surprisingly low levels of regulatory cytokines, such as IL-10 and TGF-b.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Environmental Exposures
Epstein-Barr virus has interested lupus researchers as one early trigger of autoimmunity. In a 2019 paper, Dr. James and her colleagues recontacted 436 family members of SLE patients who did not have the disease at baseline to see if they had transitioned to classified disease within a 6.3-year follow-up period.12

Analyzing blood samples, researchers measured patients’ antibodies against Epstein-Barr viral capsid antigen and early antigen. They found transitioning patients had higher levels of anti-early antigen antibodies and serological evidence of Epstein-Barr virus reactivation. Their recent research also identified environmental factors that may increase family members’ transition risk, including vitamin D deficiency, especially if individuals also have risk alleles for a single-nucleotide polymorphism in the CYP24A1 allele, and sleeping less than seven hours per night.13,14

Possible Protective Factors
Of women in the U.S., up to 30% will have a positive ANA test at some point, but few develop systemic autoimmune disease, Dr. James said. How are they able to escape the development of autoimmune disease?

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Using the Oklahoma Immune Cohort of 789 individuals, she and her colleagues found 57 individuals who were ANA positive and had anti-dsDNA, anti-chromatin, anti-Ro, anti-La, anti-Sm and other lupus-associated autoantibodies. “We also looked at the racial composition of those individuals who were autoantibody-positive,” she said. “African Americans were on the lower end of positivity, with only 4.0% having one of these autoantibody specificities. Native Americans had the highest rate of autoantibodies and European Americans were in the middle. When we looked at multivariable logistic regression, only female sex was a significant, independent predictor.”15

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: 2019 ACR/ARP Annual Meeting, environmental factor, genetic, SLE, systemic lupus erythematosus (SLE)Issue: March 2020

You Might Also Like:
  • Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus
  • 2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed
  • New Study Reveals Limitations in ANA Test Kits for Lupus
  • Study Reveals Role of IL-17–Secreting CD4+ T Cells in Lupus

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)